Markets:

Overview

News

Currencies

International

Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

0.8311 -0.0511 (-5.79%)

Streaming Delayed Price Updated: 1:18 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evogene Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

Evogene Ltd (NASDAQ:EVGN) Reports Q4 Revenue Beat but Wider-Than-Expected Loss, Shares Drop ↗

March 05, 2026

Via Chartmill

Why Did EVGN Shares Drop More Than 14% Today? ↗

February 10, 2026

Via Stocktwits

Climateflation and Water Scarcity: A Global Food Crisis with Dire Implications for Africa

December 12, 2025

The world is currently grappling with a potent and dangerous cocktail of climate change impacts and water scarcity, giving rise to a phenomenon dubbed "climateflation." This escalating crisis is...

Via MarketMinute

What's Next: Evogene's Earnings Preview ↗

November 19, 2025

Via Benzinga

Preview: Evogene's Earnings ↗

August 18, 2025

Via Benzinga

Insights into Evogene's Upcoming Earnings ↗

May 20, 2025

Via Benzinga

A Glimpse of Evogene's Earnings Potential ↗

November 20, 2024

Via Benzinga

Earnings Scheduled For November 20, 2025 ↗

November 20, 2025

Via Benzinga

Evogene Ltd (NASDAQ:EVGN) Reports Mixed Q2 2025 Results, Beats EPS Estimates But Misses on Revenue ↗

August 19, 2025

Evogene (EVGN) reported Q2 2025 results, missing revenue estimates but beating on EPS. The stock saw a modest pre-market gain as investors focused on the narrower-than-expected loss.

Via Chartmill

Earnings Scheduled For August 19, 2025 ↗

August 19, 2025

Via Benzinga

Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud ↗

June 10, 2025

The company said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models.

Via Stocktwits

Topics Artificial Intelligence

Top movers in Tuesday's after hours session ↗

June 10, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of “FOCUSfactor®” Energy Drink – More Stocks Moving Inside

June 10, 2025

Via AB Newswire

Power Metallic (TSXV: PNPN) (OTCQB: PNPNF) Positioned for Critical Minerals Breakout Following Acquisition – More Stocks Inside

June 10, 2025

Via AB Newswire

Dow Gains 50 Points; US Small Business Optimism Index Rises In May ↗

June 10, 2025

Via Benzinga

Topics Stocks

Which stocks are moving on Tuesday? ↗

June 10, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Which stocks are gapping on Tuesday? ↗

June 10, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results ↗

June 10, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Tuesday. ↗

June 10, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

Earnings Scheduled For May 21, 2025 ↗

May 21, 2025

Via Benzinga

Unusual volume stocks in Tuesday's session ↗

April 22, 2025

On Tuesday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

Stocks in Oversold Territory: EVGN, MLGO, PRSO, SHFS – More Undervalued Players Worth Watching Inside

April 22, 2025

Via AB Newswire

Topics Artificial Intelligence Intellectual Property

Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI ↗

April 21, 2025

Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals.

Via Benzinga

Earnings Scheduled For November 21, 2024 ↗

November 21, 2024

Via Benzinga

EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024 ↗

August 22, 2024

EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024 ↗

May 23, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023 ↗

March 07, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party' ↗

March 07, 2024

Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported...

Via Benzinga

Topics Cannabis

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.